All news

Global Arbidol Hydrochloride Market Size, Share, Value, And Competitive Landscape 2021 – 2026

Global Arbidol Hydrochloride Market is valued approximately at USD XXX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Arbidol Hydrochloride is a Russia-made powerful broad-spectrum antiviral which is used for the treatment of number of enveloped and non-enveloped viruses. The drug is majorly used in Russia and China and is effective in treating influenza A & B viruses and hepatitis C virus. Hence the growing number of diseases due to the spread of new type of viruses drives the market for Arbidol. As the virus spreads, the diseases turn into an epidemic and hence the demand for Arbidol Hydrochloride surges. For Instance: In 2020 the spread of the COVID-19 turned into a Pandemic which has created a huge demand for Arbidol for treatment of the disease. As per World of meters, as of 2nd May 2020 the number of Coronavirus Cases have increased to 3.4 million while the death toll from this virus has reached to 239 thousand. The spread of the virus has initiated large number of clinical trials trying to create an effective treatment and vaccine for the disease. These clinical trials involve usage of Arbidol Hydrochloride for treatment. As the national Health Commission of China, in February 2020 issued a guidance selecting Lopinavir-ritonavir and Arbidol for treating COVID-19. The decision for the selection was based on in-vitro cell tests and previous clinical data from SARS and MERS. This further led to an increase in production of Arbidol Hydrochloride in China. As Shijiazhuang Pharmaceutical Group since Mid-January has donated 50,000 boxes of arbidol tablets to the medical staff in Wuhan and since then more orders for the medicine have come in from the clinical medical institutions. The company can produce 900 thousand of Arbidol Hydrochloride capsules per day which is about twice the normal daily volume of production. Also, the Hyderabad-based Indian Institute of Chemical Technology (IICT) has developed a convenient and cost-effective synthetic process for producing antiviral drug Favipiravir. Along with the drug, the institute is working on the production of other drugs namely, Arbidol and Triazavarin for the battling the pandemic. Hence the surge in demand owing to the rising clinical trials has led to the increase in production of arbidol tablets and capsules driving the market towards growth. However, unsuccessful trials impede the growth of the market over the forecast period of 2020-2026.


The regional analysis of global Arbidol Hydrochloride market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of urgent care services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising disposable income, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Arbidol Hydrochloride market across Asia-Pacific region.


Major market player included in this report are:
JSC Pharmstandard
Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
Yichang Tianren Pharmaceutical Co.,Ltd
Shenyang Coupling Biomedical Technology Co., Ltd.
Shijiazhuang Pharmaceutical Group

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Arbidol Hydrochloride Tablets
Arbidol Hydrochloride Capsules
Arbidol Hydrochloride Granules
By Application:
Anti Influenza Virus
By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Arbidol Hydrochloride Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Arbidol Hydrochloride Market, by Region, 2018-2026 (USD Billion)
1.2.2. Arbidol Hydrochloride Market, by Product, 2018-2026 (USD Billion)
1.2.3. Arbidol Hydrochloride Market, by Application, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Arbidol Hydrochloride Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Arbidol Hydrochloride Market Dynamics
3.1. Arbidol Hydrochloride Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Arbidol Hydrochloride Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Arbidol Hydrochloride Market, by Product
5.1. Market Snapshot
5.2. Global Arbidol Hydrochloride Market by Product, Performance – Potential Analysis
5.3. Global Arbidol Hydrochloride Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. Arbidol Hydrochloride Market, Sub Segment Analysis
5.4.1. Arbidol Hydrochloride Tablets
5.4.2. Arbidol Hydrochloride Capsules
5.4.3. Arbidol Hydrochloride Granules
Chapter 6. Global Arbidol Hydrochloride Market, by Application
6.1. Market Snapshot
6.2. Global Arbidol Hydrochloride Market by Application, Performance – Potential Analysis
6.3. Global Arbidol Hydrochloride Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Arbidol Hydrochloride Market, Sub Segment Analysis
6.4.1. Anti Influenza Virus
6.4.2. COVID-19
Chapter 7. Global Arbidol Hydrochloride Market, Regional Analysis
7.1. Arbidol Hydrochloride Market, Regional Market Snapshot
7.2. North America Arbidol Hydrochloride Market
7.2.1. U.S. Arbidol Hydrochloride Market Product breakdown estimates & forecasts, 2016-2026 Application breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Arbidol Hydrochloride Market
7.3. Europe Arbidol Hydrochloride Market Snapshot
7.3.1. U.K. Arbidol Hydrochloride Market
7.3.2. Germany Arbidol Hydrochloride Market
7.3.3. Rest of Europe Arbidol Hydrochloride Market
7.4. Asia-Pacific Arbidol Hydrochloride Market Snapshot
7.4.1. China Arbidol Hydrochloride Market
7.4.2. India Arbidol Hydrochloride Market
7.4.3. Japan Arbidol Hydrochloride Market
7.4.4. Rest of Asia Pacific Arbidol Hydrochloride Market
7.5. Latin America Arbidol Hydrochloride Market Snapshot
7.5.1. Brazil Arbidol Hydrochloride Market
7.5.2. Mexico Arbidol Hydrochloride Market
7.6. Rest of The World Arbidol Hydrochloride Market



[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105